News und Analysen
DGAP-News: MorphoSys und Incyte geben weitere 'Real World' Ergebnisse der RE-MIND2-Studie mit Tafasitamab (Monjuvi(R)) in Kombination mit Lenalidomid zur Behandlung des R/R DLBCL bekannt
DGAP-Adhoc: United Internet AG: Ralph Dommermuth prüft Angebote zu außerbörslichen Paketerwerben von Aktien an der United Internet AG
DGAP-Adhoc: United Internet AG: Ralph Dommermuth assesses offers for block acquisitions of shares in United Internet AG
First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell disease
Vifor Pharma today announced that the first patient has been enrolled in a double-blind, randomized phase-IIa clinical trial evaluating the safety, efficacy and tolerability of vamifeport in adult
RPM to Announce Fiscal 2022 Second-Quarter Results on January 5, 2022
RPM International Inc. (NYSE: RPM) announced today that it will release its financial results for the fiscal 2022 second quarter ended November 30, 2021, before the stock market opens on Wednesday
Guidewire Announces NXT Level Technologies as New Consulting Alliance Partner
Guidewire (NYSE: GWRE) announced that NXT Level Technologies, an insurance IT services provider specializing in Guidewire products, has joined Guidewire PartnerConnect as a Consulting alliance
Aurubis AG: Aurubis AG and Wärme Hamburg GmbH to further expand Germany's largest industrial heat system
Aurubis AG: Aurubis AG und Wärme Hamburg GmbH bauen größte Industriewärmeversorgung Deutschlands weiter aus
Eurofins Enhances Clinical and COVID-19 Testing Offering in Japan Through Acquisition of Genetic Lab Co.,Ltd.
Eurofins Scientific (EUFI.PA), the global scientific leader in bioanalytical testing and a leader in clinical diagnostics testing, announces a share purchase agreement with Transgenic Inc
Vifor Pharma appoints Hervé Gisserot as new Chief Commercial Officer and member of the Executive Committee
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor Pharma Group today announced the appointment of Hervé Gisserot as Chief Commercial Officer and member of the Vifor Pharma
Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211209006035/en/
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor
DGAP-News: Stabilus S.A. bestätigt vorläufige Zahlen für GJ2021 und schlägt Dividende von 1,25 € je Aktie vor
DGAP-News: Stabilus S.A. confirms preliminary figures for FY2021 and proposes dividend of €1.25 per share
Vici Properties Inc. Declares Regular Quarterly Dividend
VICI Properties Inc. (NYSE: VICI) (“VICI Properties” or the “Company”) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.36 per share of common stock
DGAP-News: 1&1 signs contracts with Vantage Towers and 1&1 Versatel for roll-out of its mobile network and publishes forecast for fiscal year 2022
DGAP-News: 1&1 AG schließt Verträge mit Vantage Towers und 1&1 Versatel für den Rollout ihres Mobilfunknetzes und veröffentlicht Prognose für das Geschäftsjahr 2022
DGAP-News: United Internet mit Ausblick 2022 und Vertragsabschlüssen zum Rollout des Mobilfunknetzes
DGAP-News: United Internet announces 2022 outlook and contract signings for mobile network roll-out
DGAP-Adhoc: United Internet announces 2022 outlook
AMN Named Among Top Corporate Boards in Diversity, Equity, and Inclusion Awards
The AMN Healthcare Board of Directors is one of 10 boards nationwide named as best of the best and finalists for the 2021 National Association of Corporate Directors (NACD) Diversity, Equity &
DGAP-Adhoc: Stabilus S.A.: Management Board and Supervisory Board propose dividend of €1.25 per share for fiscal year 2021
DGAP-Adhoc: Stabilus S.A.: Vorstand und Aufsichtsrat schlagen Dividende in Höhe von 1,25 € je Aktie für Geschäftsjahr 2021 vor
NICE Actimize Positioned as Overall Leader in the 2021 Quadrant Knowledge Trade Surveillance and Monitoring Report
NICE Actimize, a NICE (Nasdaq: NICE) business, has been ranked by global advisory and consulting firm Quadrant Knowledge Solutions as the overall global Leader in its report titled “SPARK Matrix™
DGAP-News: GEA among Germany's most sustainable companies with double 'A' from CDP
DGAP-News: GEA erzielt Doppel 'A' im CDP-Rating und gehört damit zu den nachhaltigsten Unternehmen Deutschlands